<?xml version="1.0" encoding="UTF-8"?>
<ref id="B30-marinedrugs-18-00254">
 <label>30.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Treanor</surname>
    <given-names>J.J.</given-names>
   </name>
   <name>
    <surname>Hayden</surname>
    <given-names>F.G.</given-names>
   </name>
   <name>
    <surname>Vrooman</surname>
    <given-names>P.S.</given-names>
   </name>
   <name>
    <surname>Barbarash</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Bettis</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Riff</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Singh</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Kinnersley</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Ward</surname>
    <given-names>P.</given-names>
   </name>
   <name>
    <surname>Mills</surname>
    <given-names>R.G.</given-names>
   </name>
  </person-group>
  <article-title>Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza: A randomized controlled trial. US oral neuraminidase study group</article-title>
  <source>JAMA</source>
  <year>2000</year>
  <volume>283</volume>
  <fpage>1016</fpage>
  <lpage>1024</lpage>
  <pub-id pub-id-type="doi">10.1001/jama.283.8.1016</pub-id>
  <pub-id pub-id-type="pmid">10697061</pub-id>
 </element-citation>
</ref>
